Sun Pharmaceutical Industries Ltd. and IriSys, LLC, among others, are the major players in the global antispasmodic and anticholinergic H2 blocking agents’ market.
The expanding anticholinergic medicine market is driving the global antispasmodic and anticholinergic H2 blocking agents’ market. The anticholinergic drugs market is expected to grow at a CAGR of 4% in the forecast period of 2022-2027.
Antispasmodics and anticholinergics are a class of medicines such as natural belladonna alkaloids, including belladonna, atropine, scopolamine, hyoscyamine, and other medications. This class of medication is used to treat cramps and spasms of the intestines, stomach, and bladder. These medications are used with antacids and other medicines to treat ulcers, vomiting, nausea, and motion sickness. Antispasmodics and anticholinergics can also be used to treat poisoning caused by various medications, mushrooms, and organic pesticides.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is a significant region in the antispasmodic and anticholinergic industry and is expected to remain a dominant region in the future. The region's growth is mainly fuelled by the expanding medical sector. Europe and the Asia Pacific are also anticipated to be major regions for the industry in the future. The increasing demand in developing economies such as China and India in order to enhance their infrastructure and diagnostic facilities is expected to boost the market growth of antispasmodic and anticholinergic H2 blocking agents.
Headquarters: Goregaon, Mumbai
Sun Pharmaceuticals Industries Limited is an Indian multinational pharmaceutical company which manufactures and sells pharmaceutical products and active pharmaceutical ingredients (APIs) majorly in India and United States. The company is one of the largest pharma companies in India and the fourth largest in the world. The company is primarily involved in offering formulations in various therapeutic areas, such as cardiology, psychiatry, neurology, gastroenterology, and diabetology.
Headquarters: San Diego, United States
IRISYS, LLC is a United States-based company that is mainly involved in providing contract pharmaceutical product development and manufacturing services to move compounds from early research to Phase I/II clinical trials. The company specialises in the formulation and research and development and manufacturing practices, manufacturing clinical trial materials, and specialty pharmaceutical products.
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.